🔗 Share this article

An underground market for unlicensed slimming medications is being driven by social media fitness personalities and vendors on messaging platforms, based on new investigations.

Investigational Treatment Gaining Traction Via Social Media

The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its supposed weight-reducing effects. Viewers are urged to message these profiles directly for source information, while also receiving discount codes.

Thriving Trade on Social Networks

Separately, a flourishing trade exists on messaging services, where communities with numerous of participants share “before and after” photos, injection guides and assertions of next-day British shipping. Vendors market the drug there before redirecting buyers to WhatsApp for purchases.

Learning About Retatrutide

Retatrutide is an investigational injection created by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials indicate it could assist patients reduce up to 25% of their total weight. Referred to as the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Medical Professionals Express Worries

Nevertheless, physicians and pharmacists have cautions that the distribution of what is still an unlicensed drug in the UK is a cause for concern and could result in users injecting substances of unknown origin.

Several professionals stated the demand for retatrutide could be connected to the increasing cost of licensed weight loss treatments such as Mounjaro.

Regulatory Position and Implementation

Marketing retatrutide on TikTok or Telegram is prohibited in the UK, as it is an unapproved drug that must not be marketed or supplied for human use under the British medical regulations.

Several influencers try to circumvent the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and distribution can still violate pharmaceutical, advertising, and consumer regulations, risking penalties, legal action or prison.

Service Reaction and Material Elimination

According to TikTok, the platform has taken down violative material and prohibited associated keywords and search suggestions. The company stated it was dedicated to keeping the service secure and investing in enhancing compliance measures.

Digital Marketplace Operations

Investigations also discovered groups with up to nine thousand members selling retatrutide using Telegram's built-in discovery tool, which functions like a public directory. Entering “retatrutide” instantly brings up groups with numerous of users, filled with images of weight loss, positive reviews and step-by-step guides for mixing or administering at home.

Within moments of joining one group, a vendor shared WhatsApp details, where most transactions take place. The seller sent an instruction manual and promised delivery within two days. When questioned whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. Not one inquired about weight, medical conditions or previous experience.

Product Information and Costs

Inside these groups, posts show black plastic packages with Royal Mail stickers, stating to include new batches. One message read: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, mixed at residence with purified liquid, or pre-filled pens typically priced at £160 for 20mg. When asked how long a pen should be used, sellers give conflicting answers ranging from a several days to “depends on your body”.

Platform Moderation and Safety Actions

A spokesperson for the messaging service stated it actively moderated harmful content on its service including content that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are administering materials they can’t verify. Even if the science behind retatrutide is sound, these digital versions may not include what they advertise,” stated a pharmacy expert, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of an online medical service connected the surge in demand to recent price rises for approved slimming drugs such as Mounjaro. “With prices rising, patients are turning to online platforms. But counterfeit injections are highly risky. You cannot know what’s inside or whether the conditions they were made in was clean,” she said.

Her team has already seen patients harmed by self-injection from unverified sources. “We recognize the disappointment, but purchasing from Telegram or communication platforms is taking chances with your well-being,” stated Wyllie. “These materials could be impure or improperly measured.”

Producer Position

A spokesperson from the pharmaceutical company said the substance was in third stage research studies and had not been evaluated or authorized by any government authority anywhere in the world. “Consequently at this time no one can sell [it] for personal consumption,” they explained, adding that any product “misleadingly claiming itself as a Lilly experimental product not yet authorized … may expose users to potentially serious medical dangers”.